Larry Wittenberg is a senior partner in Goodwin’s Technology Companies & Life Sciences Group and Co-Chair of the firm’s Healthcare Technology and Services Practice.
He has more than 30 years’ experience representing life science and healthcare technology companies, ranging in size from start-ups to public companies, in corporate and intellectual property transactions and general corporate matters. This work has included numerous venture capital financings, public offerings, mergers and acquisitions, strategic alliances, joint ventures, licenses and technology transfer agreements. Mr. Wittenberg also represents venture capital groups on their investments in life sciences companies and investment banks in connection with public and private financings. Mr. Wittenberg is a key contributor to Goodwin’s Founders Workbench, an online resource for start-ups, emerging companies and the entrepreneurial community. He has structured and negotiated corporate partnering transactions with numerous global pharmaceutical companies. Mr. Wittenberg co-founded the firm’s Life Sciences Practice and previously served as Co-Chair of that practice and as national Co-Chair of Goodwin’s Technology Companies & Life Sciences Group.
Mr. Wittenberg serves on the board of directors of MassBio, an association of more than 600 biotechnology companies, universities, academic institutions and others dedicated to advancing cutting edge research.
Prior to joining Goodwin, Mr. Wittenberg was a partner in the Business Practice Group at Testa, Hurwitz & Thibeault, where he co-founded and headed its Life Sciences Practice.
Mr. Wittenberg has been selected for inclusion in U.S. News-Best Lawyers.